← Leaderboards
Jamal S Lewis
Onevax, Llc
$5,020,103
Attributed
$5,020,103
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $899.7K · FY2013–25$1M$750K$500K$250K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,020,103 · 4
By mechanism
R35$2,757,748 · 1
R01$1,885,195 · 1
R43$226,205 · 1
R03$150,955 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Dendritic Cells”
- Barton F Haynes · Duke University$112,608,041
- Constance Ann Benson · University Of California, San Diego$65,790,143
- David Heimbrook · Leidos Biomedical Research, Inc.$56,453,265
- James C. Paulson · Scripps Research Institute$41,568,802
- Ulrich H Von Andrian · Harvard Medical School$32,521,007
- Donald L Morton · John Wayne Cancer Institute$29,042,629
Research focus
Dendritic CellsBiocompatible MaterialsMissionPreventionImmunotherapeutic AgentResearch SupportImmunoregulationEngineeringPhagocytesParticulateVaccinesImmuneCellsMacrophageResearch And DevelopmentVaccine DeliveryIn VivoInvestigationImmune SystemDesignParticleProgramsPharmaceutical PreparationsPhenotype
Grant awards (16)
Leveraging Engineering Approaches to understand Cryptococcal Vomocytosis from Immune Cells$403,650
R35 · FY2025 · GM · contact PI
Leveraging Engineering Approaches to understand Cryptococcal Vomocytosis from Immune Cells$403,931
R35 · FY2024 · GM · contact PI
Particulate-based in vivo modulation for immunotherapy of Rheumatoid Arthritis$330,872
R01 · FY2023 · AI · contact PI
Particulate-based in vivo modulation for immunotherapy of Rheumatoid Arthritis$344,130
R01 · FY2022 · AI · contact PI
Particulate-based in vivo modulation for immunotherapy of Rheumatoid Arthritis$392,500
R01 · FY2021 · AI · contact PI
Decoding vomocytosis for cell-medaited, intra-lymph nodal delivery of microparticle vaccines$378,106
R35 · FY2021 · GM · contact PI
Particulate-based in vivo modulation for immunotherapy of Rheumatoid Arthritis$445,550
R01 · FY2020 · AI · contact PI
Decoding vomocytosis for cell-medaited, intra-lymph nodal delivery of microparticle vaccines$378,792
R35 · FY2020 · GM · contact PI
SUGAR-COATING HYPOALLERGENS - A NOVEL APPROACH FOR SHELLFISH ALLLERGY IMMUNOTHERAPY$75,404
R03 · FY2020 · AI · contact PI
Decoding vomocytosis for cell-medaited, intra-lymph nodal delivery of microparticle vaccines$379,444
R35 · FY2019 · GM · contact PI
Particulate-based in vivo modulation for immunotherapy of Rheumatoid Arthritis$372,143
R01 · FY2019 · AI · contact PI
SUGAR-COATING HYPOALLERGENS - A NOVEL APPROACH FOR SHELLFISH ALLLERGY IMMUNOTHERAPY$75,551
R03 · FY2019 · AI · contact PI
Decoding vomocytosis for cell-medaited, intra-lymph nodal delivery of microparticle vaccines$58,803
R35 · FY2019 · GM · contact PI
Decoding vomocytosis for cell-medaited, intra-lymph nodal delivery of microparticle vaccines$380,065
R35 · FY2018 · GM · contact PI
Decoding vomocytosis for cell-medaited, intra-lymph nodal delivery of microparticle vaccines$374,957
R35 · FY2017 · GM · contact PI
Polymeric biomaterial-based microparticle vaccine for amelioration of Type 1 diab$226,205
R43 · FY2013 · DK · contact PI